24,669 results on '"ADALIMUMAB"'
Search Results
2. Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis (SELECT- SWITCH)
3. A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA-BRIDGE)
4. A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
5. A Study of Baricitinib in Participants With Rheumatoid Arthritis (RA-BRANCH)
6. A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis
7. Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
8. Diabetes Islet Preservation Immune Treatment (DIPIT)
9. Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Setting (HYRISS)
10. Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy (SOPRANO-CD)
11. Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis (SMOOTH)
12. Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (LEVENTA)
13. Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa
14. Korean College of Rheumatology Biologics and Targeted Therapy Registry (KOBIO)
15. Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis
16. A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
17. Effects of TNF Blockade on Human BPH/LUTS
18. Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity
19. Adalimumab Drug Optimisation in Rheumatoid Arthritis Using Therapeutic Drug Monitoring (ADDORA)
20. Evaluation of TWEAK in Plaque Psoriasis and Psoriatic Arthritis Patients
21. Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration. (VEDIAN)
22. Stand UP to Rheumatoid Arthritis (SUPRA) (SUPRA)
23. A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis (BE OPTIMAL)
24. Application of N-of-1 Rheumatoid Arthritis
25. Infliximab and Adalimumab in Inflammatory Bowel Disease Patients.
26. A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
27. Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious Uveitis
28. Comparison Between Infliximab and Adalimumab on Patients With Ulcerative Colitis
29. Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis
30. Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease (GUIDE)
31. Adalimumab in JIA-associated Uveitis Stopping Trial (ADJUST)
32. A Clinical Study With Adalimumab Biosimilar
33. Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis (STARA)
34. Juvenile Idiopathic Arthritis (JIA) Registry (STRIVE)
35. A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis
36. Treatment FOr Corticosteroid Dependent UveitiS (FOCUS)
37. A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis
38. A Study to Evaluate 608 in Patients With Ankylosing Spondylitis (AS)
39. Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis (CRI-RA)
40. CHronic Nonbacterial Osteomyelitis International Registry (CHOIR) (CHOIR)
41. Precision Crohn's Disease Management Utilizing Predictive Protein Panels (ENvISION) (ENvISION)
42. Biologic Tapering Study of TNF Inhibitors in Axial Spondyloarthritis (BIOTAPE)
43. Immunoclassification of Psoriasis: a Strategy for Precision Medicine
44. Study on Patients With Rasmussen Encephalitis Treated With Adalimumab: Efficacy and Tolerance in the Short and Long Term
45. Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
46. Adalimumab to treat noninfectious pediatric chronic anterior uveitis: a case series.
47. 6‐Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy.
48. Dynamics and implications of anti-drug antibodies against adalimumab using ultra-sensitive and highly drug-tolerant assays.
49. Adalimumab-induced manic episode in an adolescent with juvenile idiopathic arthritis.
50. SERENE ER Analysis Part 1‐SERENE CD: Exposure‐Response Analysis of Higher Versus Standard Adalimumab Dosing Regimens for Patients With Moderately to Severely Active Crohn Disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.